研究单位：[1]neurology department,Xuanwu Hospital,Beijing[2]Zhongshan Hospital,Xiamen University Xiamen,Fujian,China[3]Nanfang Hospital,Southern Medical University Guangzhou,Guangdong,China[4]Xiangya Hospital,Central South University Changsha,Hunan,China[5]Xijing Hospital Shanxi,Xi'an,China[6]The First People's Hospital of Yunnan ProvinceKunming,Yunnan,China
研究目的：
Although generalized convulsive status epilepticus (GCSE) is a life-threatening emergency, evidence-based data to guide initial drug treatment choices are lacking in the Chinese population. The investigators conduct this prospective randomized controlled trial to evaluate the relative efficacy and safety of intravenous (IV) phenobarbital (PB) and valproate (VPA) in patients with GCSE.
